Cardiovascular Disease in People with HIV

Cardiovascular Disease in People with HIV

Release Date: August 9, 2022
Expiration Date: August 9, 2023
Estimated Time to Complete: 1.0 hour


Activity Description

Heart disease is increased in people with HIV and is a clinical and public health priority. This free interactive CME/CNE-Certified webinar is designed for members of the care team to help you work together to identify those at risk in your care and apply best practices for the prevention and management of cardiovascular disease in PWH.

Learning Objectives

After participating in the activity, learners should be better able to:
  • Review the epidemiology of cardiovascular disease in HIV
  • Describe the mechanism of and risk factors for cardiovascular disease in HIV
  • Collaborate with your care team to apply best practices in prevention and management of cardiovascular
    disease in HIV

Activity Faculty

Virginia Athena Triant, M.D., M.P.H.
Clinician and Clinical Investigator
Divisions of Infectious Diseases and General Internal Medicine
Massachusetts General Hospital

Faculty Bios

Dr. Triant is a clinician and clinical investigator in the Infectious Diseases and General Internal Medicine Divisions at Massachusetts General Hospital (MGH) dedicated to studying the long-term non-communicable disease and aging-related complications of HIV infection. The focus of Dr. Triant’s research has been on the intersection between HIV and cardiovascular disease and non-communicable chronic disease complications. She has investigated rates and determinants of clinical outcomes such as myocardial infarction, stroke, and fracture in HIV and is currently investigating optimal cardiovascular risk prediction strategies in HIV and HIV/HCV co-infected individuals. She is also actively engaged in clinical outcomes and population-based studies of infective endocarditis and COVID-19. Dr. Triant is an active infectious diseases clinician, maintaining an outpatient clinic and attending on the infectious diseases consult service at MGH. Through research, clinical care, and mentoring activities, she brings a cross-disciplinary approach to clinical outcomes research with the goal of improving long term outcomes and enhancing the care and well-being of vulnerable populations.

Accreditation and Credit Designation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and ACTHIV Institute. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.



American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity..

Nurse Practitioners and Nurses

American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours
(0.3 Pharmacotherapeutic Contact Hours).

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.0 contact hours.

Physician Assistants

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until August 9th, 2023. PAs should only claim credit commensurate with the extent of their participation.

Other members of the care team will receive a certificate of participation.

Target Audience

This activity has been designed to meet the educational needs of the HIV care team, including physicians (both specialists and primary care/family medicine), nurses, nurse practitioners, physician assistants, and pharmacists who are in practice but are newer to HIV medicine or who are in training. Other healthcare providers may also participate.


According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of relevant financial relationships are as follows:

Faculty Educator

Virginia Triant, MD, MPH has no relevant financial relationships with ineligible companies to disclose.

Planning Committee

The following individuals have no relevant financial relationships with ineligible companies to disclose:
Jose Castillo-Mancilla, MD
Donna Futterman, MD
John JD Juchniewicz, MCIS, CHCP, FACEHP
Natalie Kirkwood, RN, BSN, JD
Vincent Lo Re, MD, MSCE
Paul Miniter, MS
Edward Moylan, RP
Dianne Rausch, PhD

The following individuals have relevant financial relationships with ineligible companies to disclose:

Roger Bedimo, MD, MS: Advisory Board/Consultant – Merck, ViiV Healthcare, Theratechnologies*

Igho Ofotokun, MD, MSc: Grant/Research Support – Merck

Melanie Thompson, MD: Grant/Research Support – Cepheid Inc, Cytodyn Inc, Frontier Biotechnologies, Gilead Sciences, GlaxoSmithKline, Merck, ViiV Healthcare

*Indicates relationship has ended

This activity will contain discussion off-label information

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Instructions on How to Receive Credit

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CE credit for your participation, please complete the post-assessment and program evaluation. Your certificate will be available for printing immediately.

Privacy and Contact

For more information about the American Academy of CME privacy policy, please access  For any questions, please contact: [email protected].

Hardware/Software Requirements

This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended.


© 2022. This accredited continuing education activity is held as copyrighted © by American Academy of CME. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).